In an attempt to protect themselves against future uncertainty, Indian pharmaceutical companies are rapidly increasing their US footprint through a series of acquisitions. Prominent companies including Senores, Zydus, Sun Pharma, and Syngene...
Caliber, the industry's premier provider of digital solutions to the pharmaceutical and biotech industries, unveiled four new products aimed at driving...
Zynext Ventures USA (Zynext Ventures), the venture capital division of Zydus Lifesciences (Zydus), has made an investment in Illexcor Therapeutics (Illexcor)...
Zydus Lifesciences Limited, a global innovation-driven life sciences company, began exclusive negotiations to acquire an 85.6 percent stake in Amplitude Surgical, whereby the deal is proposed by...
Capitalizing on demographic factors, technological advancements, and increasing demand for quality and preventive care, the healthcare sector of...
Syngene International acquired its first biologics manufacturing site in the United States at $36.5 million, a major expansion in the...
The Department of Pharmaceuticals has invited expression of interest from entities for the purpose of project funding under the Promotion...
Zydus Lifesciences Limited has acquired final permission from the US Food and Drug Administration (USFDA) to manufacture 2% ketoconazole shampoo. According to the company's release today.
Union Minister Jitendra Singh announced the establishment of BioE3 Cells in states to function as interconnected knowledge centers that will nurture the biomanufacturing sector of India. BioE3 Cells positioned between state and national stakeholders
India is fast emerging as a key hub for Global Capability Centers (GCCs), changing the way businesses do their work globally. Digital transformation and rapid advancements...
, CDSCO.jpg)
